InSilico Medicine jumps 10.7% after nominating ISM1354 obesity drug pre-clinical candidate
Shares of InSilico Medicine Cayman TopCo rose 10.7% to HK$61.35, the biggest one-day percentage gain since Sept 18, as it nominated ISM1354 as a pre-clinical candidate for potential obesity intervention and other related disorders.